Michael Sejer Hansen

Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti–tumor necrosis factor α therapy: Results from the nationwide Danish DANBIO registry

Bente Glintborg, Mikkel Østergaard, Lene Dreyer et al. · Arthritis & Rheumatism · 2010 · 245 citations

Medicine, Internal Medicine, Pharmacotherapy +17

No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study

Uffe Møller Døhn, Bo Ejbjerg, Annelies Boonen et al. · Annals of the Rheumatic Diseases · 2010 · 159 citations · Full text

Medicine, Clinical Sciences, Radiology +17

Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study

Maxime Dougados, K. Kissel, Philip G. Conaghan et al. · Annals of the Rheumatic Diseases · 2014 · 152 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor α inhibitors

Susanne Juhl Pedersen, Inge Juul Sørensen, Kay‐Geert Hermann et al. · Annals of the Rheumatic Diseases · 2009 · 120 citations

Medicine, Pharmacotherapy, Inflammation +15

Bone edema on magnetic resonance imaging is an independent predictor of rheumatoid arthritis development in patients with early undifferentiated arthritis

Anne Duer‐Jensen, Kim Hørslev‐Petersen, Merete Lund Hetland et al. · Arthritis & Rheumatism · 2011 · 101 citations

Medicine, Internal Medicine, Radiology +15